BioCentury | Aug 26, 2010
Distillery Therapeutics

Indication: Cardiovascular disease

...Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Hypertension Malonyl-CoA decarboxylase (MLYCD; MCD); pyruvate...
BioCentury | Aug 26, 2010
Targets & Mechanisms

Metabolic origins for pulmonary hypertension

...could be expected to activate PDH and increase glucose oxidation. The team selected malonyl-CoA decarboxylase ( MLYCD...
...In particular, they suggest that fatty acid oxidation can be inhibited by blocking malonyl-CoA decarboxylase ( MLYCD...
Items per page:
1 - 2 of 2